GleamWall
中文EN

DRTS Alpha Tau Medical Ltd. Annual reports only

Surgical & Medical Instruments & Apparatus · Nasdaq · SEC CIK 1871321 · Fiscal year ends 12/31

Financial factors as of 2025-12-31 (FY2025), by fiscal year; growth vs the previous fiscal year

Growth

TTM revenue YoY—
TTM net income YoY-34.3%
TTM EPS YoY-17.8%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE-61.0%
ROA-44.4%
ROIC (approx.)-58.7%
Asset turnover—

Leverage & solvency

Liabilities / assets27.0%
Debt / equity0.00x
Current ratio7.45x
Interest coverage-121.87x

Cash quality & payout

Operating cash flow / net income0.63x
Accruals ratio-16.6%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Annual Quarterly (none) Export CSV 🔒
Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$32.06M$27.02M
SG&A expense$8.36M$6.67M
Operating income-$42.29M-$36.04M
Interest expense$347,000$303,000
Pretax income-$42.51M-$31.74M
Income tax$121,000$6,000
Net income-$42.63M-$31.75M
EBITDA-$41.06M-$34.94M
EPS (basic)-0.53-0.45
EPS (diluted)-0.53-0.45
Weighted avg. shares (diluted)80.58M69.93M
Balance sheet
Cash & equivalents$12.20M$13.72M
Short-term investments$60.92M$45.88M
Current assets$78.30M$64.23M
PP&E, net$19.66M$13.93M
Total assets$105.65M$86.20M
Current liabilities$10.51M$8.68M
Total liabilities$28.55M$23.54M
Shareholders' equity$77.10M$62.67M
Shares outstanding88.01M70.38M
Cash flow statement
Operating cash flow-$26.68M-$19.78M
Capital expenditure$6.08M$2.24M
Free cash flow-$32.76M-$22.02M
Investing cash flow-$20.59M$20.77M
Financing cash flow$45.77M$25,000
Depreciation & amortization$1.23M$1.10M
Stock-based compensation$10.62M$9.92M

Free plan shows the latest 2 periods; Pro shows all 7 🔒

· This company files only annual reports with the SEC (20-F for foreign issuers), so there is no quarterly data; factors are by fiscal year and growth is vs the previous fiscal year.

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.